Publication: Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines
Issued Date
2010-09-01
Resource Type
ISSN
0264410X
Other identifier(s)
2-s2.0-77956480675
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vaccine. Vol.28, No.41 (2010), 6765-6777
Suggested Citation
Kanyarat Thueng-in, Santi Maneewatch, Potjanee Srimanote, Thaweesak Songserm, Pramuan Tapchaisri, Nitat Sookrung, Pongsri Tongtawe, Sunee Channarong, Wanpen Chaicumpa Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines. Vaccine. Vol.28, No.41 (2010), 6765-6777. doi:10.1016/j.vaccine.2010.07.065 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28650
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines
Other Contributor(s)
Abstract
A non-egg, non-culture based influenza vaccine that intervenes large influenza outbreaks and protects against heterosubtypic infections is needed. Candidates of such vaccine are likely to be conserved influenza virus proteins or their coding DNA. The vaccine must be conveniently produced at reasonable cost, safe, highly immunogenic and should be able to recall rapidly the immunological memory upon the antigenic re-exposure. In this study vaccines made of full length recombinant NP and M2 of the H5N1 influenza A virus were entrapped either alone or together into liposome (L) made of phosphatidylcholine and cholesterol. The vaccines (L-NP, L-M2 or L-NP+M2) and mocks (L or PBS) were safe without causing any adverse reaction in the intramuscularly injected mice. They were readily immunogenic at a single dose and a recalled response could be detected within one day post booster. Cytokine and antibody data indicated that the vaccines induced a Th1 bias immune response. NP containing vaccines stimulated a marked increase of cytotoxic lymphocytes, i.e., CD8+, intracellular IFNγ+cells, while M2 containing vaccines elicited good antibody response which neutralized infectivity of heterologous influenza viruses. Although the three vaccines elicited different immunological defense factors; nevertheless, they similarly and readily abrogated lung histopathology mediated by viruses belonging to different H5N1 clade/subclade and heterosubtypes including swine H1N1 and human H1N1/2009 viruses. They protected the vaccinated mice against lethal challenges with mouse adapted avian H5N1 virus. The liposome adjuvanted vaccines which demonstrated high protective efficacy in mice warrant testing further in a non-rodent model as well as in humans. © 2010 Elsevier Ltd.
